K
Originally published by Kenyanstop
January 10, 2026
14h ago
Govt Clears Path for New Long-Lasting HIV Drug
The Ministry of Health, through the Pharmacy and Poisons Board, on January 10, recommended the registration of Lenacapavir 300 mg tablets and 464 mg injectable solution for pre-exposure prophylaxis (PrEP)..
✨ Key Highlights
The Kenyan government has officially approved Lenacapavir, a groundbreaking long-acting HIV prevention medication, for roll-out. This decision aims to significantly improve adherence and access to pre-exposure prophylaxis (PrEP) across the country.
- Lenacapavir is administered just twice a year, offering a more convenient alternative to daily pills.
- The approval was granted by the Ministry of Health, through the Pharmacy and Poisons Board, on January 10.
- Kenya is among the first African countries to recommend Lenacapavir for registration, aligning with World Health Organization guidance.
Continue Reading
Read the complete article from Kenyans
Advertisement
Related News
Advertisement